看來載入頁面時發生了錯誤.
我們的團隊已收到通知，但若此問題持續，請透過電郵支援widget工具聯絡我們。
| Trend | Peers | Company |
|---|---|---|
| Is return on equity increasing? | Yes | No |
| Is net profit margin increasing? | Yes | No |
| Is asset turnover increasing? | Yes | No |
| Is equity multiplier increasing? | Yes | Yes |
| Competitors Used |
|---|
| Dyadic International, Inc. |
| Onconetix, Inc. |
| Cardiff Oncology, Inc. |
| Geron Corporation |
| Trevena, Inc. |
| Return on Equity Benchmarks | ||||||||
| Comparable Companies | ||||||||
| DYAI | ONCO | CRDF | GERN | TRVN | DAWN | |||
| Return On Equity | ||||||||
| Latest Twelve Months | -139% | -234% | -60% | -66% | 344% | -22% | ||
| Fiscal Year - 1 | -80% | NA | -47% | -112% | -134% | NA | ||
| Fiscal Year - 2 | -66% | NA | -31% | -137% | -61% | NA | ||
| Fiscal Year - 3 | -56% | NA | -21% | -69% | -44% | NA | ||
| Fiscal Year - 4 | -29% | NA | -33% | -44% | -69% | NA | ||
| Fiscal Year - 5 | -21% | NA | -192% | -44% | -81% | NA | ||
| Average | -65% | -234% | -64% | -79% | -7% | -22% | ||
| Median | -61% | -234% | -40% | -67% | -65% | -22% | ||
| Benchmarks | Ticker | |||||||
| Dyadic International, Inc. | NasdaqCM:DYAI | |||||||
| Onconetix, Inc. | NasdaqCM:ONCO | |||||||
| Cardiff Oncology, Inc. | NasdaqCM:CRDF | |||||||
| Geron Corporation | NasdaqGS:GERN | |||||||
| Trevena, Inc. | OTCPK:TRVN | |||||||
| Financial Performance | ||||||||
| Comparable Companies | ||||||||
| (in millions) | DYAI | ONCO | CRDF | GERN | TRVN | DAWN | ||
| Latest Fiscal Year | Dec-24 | Dec-23 | Dec-24 | Dec-24 | Dec-23 | Dec-24 | ||
| LTM Period | Dec-24 | Sep-24 | Dec-24 | Dec-24 | Sep-24 | Dec-24 | ||
| Revenues | ||||||||
| Latest Twelve Months | 3 | 2 | 1 | 77 | 1 | 131 | ||
| Fiscal Year | 3 | 0 | 1 | 77 | 3 | 131 | ||
| Fiscal Year - 1 | 3 | NA | 0 | 0 | (0) | NA | ||
| Fiscal Year - 2 | 3 | NA | 0 | 1 | 1 | NA | ||
| Fiscal Year - 3 | 2 | NA | 0 | 1 | 3 | NA | ||
| Fiscal Year - 4 | 2 | NA | 0 | 0 | 0 | NA | ||
| Fiscal Year - 5 | 2 | NA | 0 | 0 | 6 | NA | ||
| Net Income | ||||||||
| Latest Twelve Months | (6) | (52) | (45) | (175) | (34) | (95) | ||
| Fiscal Year | (6) | (37) | (45) | (175) | (40) | (95) | ||
| Fiscal Year - 1 | (7) | (14) | (41) | (184) | (54) | (189) | ||
| Fiscal Year - 2 | (10) | (4) | (39) | (142) | (52) | (142) | ||
| Fiscal Year - 3 | (13) | (2) | (28) | (116) | (29) | (171) | ||
| Fiscal Year - 4 | (9) | (1) | (23) | (76) | (25) | (41) | ||
| Fiscal Year - 5 | (8) | NA | (17) | (69) | (31) | (13) | ||
| Total Assets | ||||||||
| Latest Fiscal Quarter Prior | 8 | 28 | 82 | 394 | 45 | 376 | ||
| Latest Fiscal Quarter | 10 | 62 | 97 | 594 | 19 | 583 | ||
| Fiscal Year | 10 | 88 | 97 | 594 | 41 | 583 | ||
| Fiscal Year - 1 | 8 | 26 | 82 | 394 | 49 | 376 | ||
| Fiscal Year - 2 | 14 | 3 | 116 | 191 | 80 | 349 | ||
| Fiscal Year - 3 | 21 | 5 | 150 | 226 | 128 | 290 | ||
| Fiscal Year - 4 | 30 | 6 | 135 | 271 | 47 | 46 | ||
| Fiscal Year - 5 | 37 | NA | 13 | 166 | 67 | 27 | ||
| Fiscal Year - 6 | 43 | NA | 14 | 185 | 73 | NA | ||
| Common Equity | ||||||||
| Latest Fiscal Quarter Prior | 6 | 10 | 70 | 248 | 4 | 347 | ||
| Latest Fiscal Quarter | 2 | 34 | 83 | 280 | (23) | 503 | ||
| Fiscal Year | 2 | (6) | 83 | 280 | (8) | 503 | ||
| Fiscal Year - 1 | 6 | 22 | 70 | 248 | 16 | 347 | ||
| Fiscal Year - 2 | 11 | 1 | 106 | 80 | 65 | 332 | ||
| Fiscal Year - 3 | 18 | 5 | 140 | 126 | 104 | 281 | ||
| Fiscal Year - 4 | 28 | 6 | 128 | 211 | 30 | (54) | ||
| Fiscal Year - 5 | 36 | NA | 7 | 135 | 42 | (11) | ||
| Fiscal Year - 6 | 42 | NA | 10 | 178 | 35 | NA | ||